Home/Filings/4/0001213900-25-090617
4//SEC Filing

HOLUBIAK MYRON Z 4

Accession 0001213900-25-090617

CIK 0001851484other

Filed

Sep 22, 8:00 PM ET

Accepted

Sep 23, 4:10 PM ET

Size

11.8 KB

Accession

0001213900-25-090617

Insider Transaction Report

Form 4
Period: 2025-09-19
HOLUBIAK MYRON Z
DirectorSecretary
Transactions
  • Award

    Common Stock

    2025-09-19+850,000850,000 total
  • Award

    Common Stock

    2025-09-19+100,000100,000 total(indirect: See footnote)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $2.15Exp: 2033-07-05Common Stock (1,500,000 underlying)
    1,500,000
  • Stock Option (Right to Buy)

    Exercise: $1.07Exp: 2034-12-12Common Stock (300,000 underlying)
    300,000
  • Stock Option (Right to Buy)

    (indirect: See footnote)
    Exercise: $1.07Exp: 2034-12-12Common Stock (50,000 underlying)
    50,000
Footnotes (5)
  • [F1]Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
  • [F2]Represents restricted stock awards granted on September 19, 2025 to the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.
  • [F3]These options were granted on December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, subject to the Reporting Person's Continuous Service to the Company or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
  • [F4]These options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.
  • [F5]These options vest over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, subject to the Reporting Person's Continuous Service to the Company or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

Issuer

CITIUS ONCOLOGY, INC.

CIK 0001851484

Entity typeother

Related Parties

1
  • filerCIK 0001199080

Filing Metadata

Form type
4
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 4:10 PM ET
Size
11.8 KB